A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer. [electronic resource]
Producer: 20050503Description: 539-48 p. digitalISSN:- 0959-8049
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Infusions, Parenteral
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Topotecan -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.